Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Lymphoid Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Early research (Phase 1)Ended earlyNCT03601819
What this trial is testing

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Who this might be right for
Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more
University of Michigan Rogel Cancer Center 4
Early research (Phase 1)Study completedNCT02240719
What this trial is testing

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
University of California, Davis 20
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Testing effectiveness (Phase 2)Looking for participantsNCT06101381
What this trial is testing

CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

Who this might be right for
Leukemia, Acute LymphoblasticLymphoma, Non-Hodgkin
University of Sao Paulo 81
Testing effectiveness (Phase 2)Ended earlyNCT02091063
What this trial is testing

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
LymphomaLymphoid Malignancies
Jennifer Amengual 23
Early research (Phase 1)Ended earlyNCT03126864
What this trial is testing

Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia

Who this might be right for
Hematopoietic/Lymphoid CancerAcute Myeloid Leukemia
M.D. Anderson Cancer Center 11
Early research (Phase 1)Study completedNCT01671904
What this trial is testing

Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Genentech, Inc. 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT03512405
What this trial is testing

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
CD19 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+1 more
City of Hope Medical Center 36
Early research (Phase 1)UnknownNCT05487651
What this trial is testing

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

Who this might be right for
NHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more
Athenex, Inc. 36
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT04623541
What this trial is testing

Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Who this might be right for
Relapsed/Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaRichter's Syndrome+1 more
Genmab 194
Early research (Phase 1)Study completedNCT03454165
What this trial is testing

BNC105P Combined With Ibrutinib

Who this might be right for
Chronic Lymphocytic Leukemia
Dartmouth-Hitchcock Medical Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439357
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 4
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Very early researchStudy completedNCT02846935
What this trial is testing

P53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies

Who this might be right for
T-cell LymphomaAggressive B-cell LymphomaNon-Hodgkin's Lymphomas+1 more
Yogen Saunthararajah 7
Early research (Phase 1)Looking for participantsNCT06208735
What this trial is testing

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Who this might be right for
B-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more
British Columbia Cancer Agency 24
Next Page